Back
Kimberly - Clark de Mexico SAB de CV Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
22
KCDMY
Kimberly - Clark de Mexico SAB de CV
Last Price:
7.03
Seasonality Move:
1.01%
Sell
46
ANIP
ANI Pharmaceuticals
Last Price:
61.01
Seasonality Move:
5.08%
Sell
22
Kimberly - Clark de Mexico SAB de CV (KCDMY)
is a Sell
Is Kimberly - Clark de Mexico SAB de CV a Buy, Sell or Hold?
- The current Kimberly - Clark de Mexico SAB de CV [KCDMY] share price is $7.07. The Score for KCDMY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KCDMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.85. The Score for ANIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KCDMY Stock Price Chart
What is Kimberly - Clark de Mexico SAB de CV's stock price today?
-
The Kimberly - Clark de Mexico SAB de CV share price today is $7.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KCDMY is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
KCDMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 34.82 | Sell |
Chaikin Money Flow: | 2542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.08 - 7.82) | Sell |
Bollinger Bands (100): | (7.68 - 9) | Sell |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 60.98 | Buy |
Chaikin Money Flow: | 213168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.73 - 59.99) | Buy |
Bollinger Bands (100): | (57.71 - 62.95) | Buy |
KCDMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.17 | Sell |
20-day SMA: | 7.3 | Sell |
50-day SMA: | 7.82 | Sell |
200-day SMA: | 9.62 | Sell |
8-day EMA: | 7.17 | Sell |
20-day EMA: | 7.35 | Sell |
50-day EMA: | 7.78 | Sell |
200-day EMA: | 9.07 | Sell |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.64 | Buy |
20-day SMA: | 58.88 | Buy |
50-day SMA: | 58.7 | Buy |
200-day SMA: | 62.08 | Sell |
8-day EMA: | 59.48 | Buy |
20-day EMA: | 58.83 | Buy |
50-day EMA: | 59.09 | Buy |
200-day EMA: | 59.9 | Buy |
Kimberly - Clark de Mexico SAB de CV Earnings Growth & KCDMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Kimberly - Clark de Mexico SAB de CV Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |